🪞 George Soros · Soros Fund Mgmt
Macro, reflexivity, big moves.
Build a basket from the top picks →
🔮 Predicted next buys: quarter ending 2026-06-30
Pure model output for George Soros · Soros Fund Mgmt’s next 13F filing, no public confirmation yet. Probabilities are the model’s raw scores.
| # | Ticker | Company | Model probability |
|---|---|---|---|
| 1 | CON | Concentra Group Holdings Par | 99% |
| 2 | LGN | Legence Corp-Cl A | 99% |
| 3 | VRNA | Verona Pharma Plc - Adr | 98% |
| 4 | SLDE | Slide Insurance Holdings Inc | 98% |
| 5 | CDTX | Cidara Therapeutics Inc | 98% |
| 6 | PCH | Potlatchdeltic Corp | 98% |
| 7 | BTSG | Brightspring Health Services | 97% |
| 8 | BETA | Beta Technologies Inc -Cl A | 96% |
| 9 | MMEUR | Millennial Media Inc | 94% |
| 10 | EXEEZ | Chesapeake Energy -Cw26 | 93% |
📉 Predicted exits, conviction fading
Of George Soros · Soros Fund Mgmt’s current disclosed holdings, the names a model flags as most likely to be EXITED or TRIMMED next quarter, before the 13F shows it. Model score (not a calibrated probability), ranked. Holdings as of 2026-03-31.
| Ticker | Company | Weight | Last move | Sell likelihood |
|---|---|---|---|---|
| VSEC | Vse Corp | 0.32% | added last Q | ▲▲▲ 73 |
| - | Clear Channel Outdoor Hldgs | 0.14% | added last Q | ▲▲▲ 72 |
| SEM | Select Med Hldgs Corp | 0.33% | added last Q | ▲▲▲ 71 |
| - | Masimo Corp | 0.20% | added last Q | ▲▲▲ 71 |
| WBD | Warner Bros Discovery Inc | 0.33% | added last Q | ▲▲ 70 |
| - | Apellis Pharmaceuticals Inc | 0.47% | added last Q | ▲▲ 69 |
| HUN | Huntsman Corp | 0.14% | trimmed last Q | ▲▲ 69 |
| SMH | Vaneck Etf Trust | 0.27% | trimmed last Q | ▲▲ 68 |
⚠️ This predicts the ACTION (whether George Soros · Soros Fund Mgmt reduces the position), not a return and not a short. A 13F shows long positions only, so a “sell” here means exiting or cutting a long, never shorting the stock. Walk-forward validated on the decision (AUC ≈ 0.66), but acting on it is not shown to make money. Research, not advice.
📜 Top disclosed holdings: Mar 2026
| Ticker | Company | Weight | Last change |
|---|---|---|---|
| SPY | State Str Spdr S&P 500 Etf T | 8.65% | ➕ Added |
| AMZN | Amazon Com Inc | 4.44% | ➖ Trimmed |
| TSM | Taiwan Semiconductor Manufac | 3.33% | ➕ Added |
| XLE | Select Sector Spdr Tr | 3.32% | ➕ Added |
| CRWV | Coreweave Inc | 2.79% | ➕ Added |
| GPN 1.5 03/01/31 | Global Pmts Inc | 2.39% | ➕ Added |
| XOP | Spdr Series Trust | 2.39% | ➖ Trimmed |
| EA | Electronic Arts Inc | 2.16% | ➕ Added |
| NVDA | Nvidia Corporation | 2.05% | ➕ Added |
| BILL 0 04/01/30 | Bill Holdings Inc | 2.05% | ➕ Added |
| PCG 4.25 12/01/27 | Pg&E Corp | 1.99% | ➕ Added |
| GOOGL | Alphabet Inc | 1.81% | ➖ Trimmed |
| JAZZ 2 06/15/26 | Jazz Investments I Ltd | 1.74% | ➖ Trimmed |
| RIVN 4.625 03/15/29 | Rivian Automotive Inc | 1.69% | ✊ Held |
| JD 0.25 06/01/29 | Jd.Com Inc | 1.64% | ➕ Added |
Source: SEC Form 13F (public domain), long U.S. equity positions only, disclosed up to 45 days after quarter-end. Top 15 of 150 shown.
💲 Where they bought: accumulation cost
13F shows holdings, not trade prices. Implied average cost is total value ÷ shares; the zone is the price range that quarter, where they accumulated. “vs cost” is today versus that average. This is where they bought, not a future price.
| Ticker | Avg cost | Accumulation zone | Today | vs cost | Dip target |
|---|---|---|---|---|---|
| SPY | $650.34 | $630–$692 | $749.17 | +15.2% | $574.50 |
| AMZN | $208.27 | $199–$247 | $247.23 | +18.7% | $205.43 |
| XLE | $61.26 | $45–$62 | $56.74 | -7.4% | $51.58 |
| CRWV | $77.47 | $69–$109 | $73.21 | -5.5% | $90.40 |
| XOP | $181.83 | $123–$187 | $170.18 | -6.4% | $155.51 |
| EA | $203.87 | $196–$204 | $207.84 | +1.9% | $169.50 |
| NVDA | $174.40 | $165–$195 | $207.40 | +18.9% | $162.20 |
| TSM | $337.95 | $316–$386 | $420.39 | +24.4% | $320.33 |
| GOOGL | $287.56 | $273–$343 | $346.77 | +20.6% | $285.04 |
| AAPL | $253.79 | $246–$278 | $333.74 | +31.5% | $230.53 |
Dip target = the recent high discounted by this investor’s historical tendency to add on weakness. Behavioral, not a guarantee.
🎯 Disclosed options: calls vs puts
13F discloses option positions too. Calls lean bullish or levered; puts lean bearish or hedging. This is the not-just-buying side of what they disclose.
| Ticker | Position | Lean |
|---|---|---|
| SPY | puts | bearish / hedge |
| XLE | puts | bearish / hedge |
| CRWV | puts | bearish / hedge |
| XOP | puts | bearish / hedge |
| TSM | puts | bearish / hedge |
| IRM | calls | bullish / levered |
| ITRI | calls | bullish / levered |
| SMH | puts | bearish / hedge |
| PONY | calls | bullish / levered |
| HUN | calls | bullish / levered |
| WOLF | calls | bullish / levered |
Source: 13F option lines (put_call). Disclosed positions, not advice.
🧬 Factor fingerprint, the style behind the book
88% of George Soros · Soros Fund Mgmt’s day-to-day swings are explained by public, buyable factors (Fama-French 5 + momentum), regressed on their current disclosed book (8 of 9 names, ~451 trading days). Market beta 1.09.
⚠️ This is the part the great investors can’t hide: their style is a tilt toward known factors, and every one of these is sold as a cheap index ETF. Buying the factors gets you most of the book for a few basis points. What’s left after the factors (the residual) is noisy on a single concentrated book and is not a reliable edge, read this as transparency about the style you’re copying, not a secret signal. Loadings are in-sample on current static weights, U.S. long positions only. Research, not advice.
📈 This mirror’s track: backtest vs S&P 500
⚠️ Read this honestly. Leak-free walk-forward backtest: top-10 predicted new buys ranked from a broad ~2,000-name universe known at the rebalance date, equal-weight, 1-quarter holds, complete quarters only, gross (before costs). Small samples, per-investor edges are noisy and not statistically significant. The consensus mirror's backtest shows +1.8 pts/quarter net vs the S&P 500 over 47 complete quarters (2014–2026), directional, NOT statistically significant (t≈1.4; 95% CI includes zero). Past performance does not predict future results. Not investment advice.
🔔 Follow this mirror
New filings and predicted-buy refreshes are published to every reader at once, weekly digest (email) · build a basket.
Prior Moves is a research publication: one impersonal model portfolio per investor, identical for every reader. You place any trades yourself at your own broker. No execution, no custody, no individualised advice.